Even more alarming, anti-TNFα therapy in rheumatoid arthritis patients has been associated with the onset of monophasic demyelination including optic neuritis that subsided after treatment withdrawal [57-60] and with the onset of MS [57,61]. The gene discussed is TNF; the disease is myeloid sarcoma.